UK markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8115+0.0215 (+2.72%)
As of 01:46PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
51,775
63,741
13,453
31,683
Other short-term investments
48,983
81,658
153,582
149,242
Total cash
100,758
145,399
167,035
180,925
Net receivables
2,765
3,260
0
-
Inventory
2,821
2,383
2,584
-
Total current assets
116,158
168,910
173,290
195,065
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
9,853
3,386
4,765
6,660
Accumulated depreciation
-1,667
-1,409
-1,161
-1,541
Net property, plant and equipment
8,186
1,977
3,604
5,119
Equity and other investments
0
11,350
69,754
70,565
Other long-term assets
1,500
-
408
408
Total non-current assets
9,686
13,327
73,766
76,092
Total assets
125,844
182,237
247,056
271,157
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
11,583
9,604
5,625
4,893
Accrued liabilities
7,490
6,717
5,277
7,033
Deferred revenues
-
-
-
0
Total current liabilities
25,592
23,458
17,616
18,483
Non-current liabilities
Other long-term liabilities
37,079
-
-
-
Total non-current liabilities
43,167
0
1,918
3,673
Total liabilities
68,759
23,458
19,534
22,156
Stockholders' equity
Common stock
54
53
53
50
Retained earnings
-684,745
-566,232
-480,758
-392,317
Accumulated other comprehensive income
-260
-1,672
-358
73
Total stockholders' equity
57,085
158,779
227,522
249,001
Total liabilities and stockholders' equity
125,844
182,237
247,056
271,157